Withdrawal of AT1 receptor antagonist, TCV-116, affects return of angiotensin I and II responses differentially in hypertensive rats

被引：0
|
作者：
Paull, JRA [1 ]
Widdop, RE [1 ]
机构：
[1] Monash Univ, Dept Pharmacol, Melbourne, Vic 3004, Australia
来源：
JOURNAL OF HYPERTENSION | 1998年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
P1553
引用
收藏
页码：S120 / S120
页数：1
相关论文
共 50 条
  • [21] Effects of TCV-116 on endothelin-1 and PDGF A-chain expression in angiotensin II-induced hypertensive rats
    Hara, K
    Kobayashi, N
    Nakano, S
    Mori, Y
    Tsubokou, Y
    Matsuoka, H
    HYPERTENSION RESEARCH, 2001, 24 (01) : 55 - 64
  • [22] Angiotensin II antagonist, TCV-116, prevents neointima formation after injured vessels in dog
    Miyazaki, M
    Takai, S
    Shiota, N
    JOURNAL OF HYPERTENSION, 1998, 16 : S127 - S127
  • [23] TCV-116, A NOVEL ANGIOTENSIN-II RECEPTOR ANTAGONIST, PREVENTS INTIMAL THICKENING AND IMPAIRMENT OF VASCULAR FUNCTION AFTER CAROTID INJURY IN RATS
    KAWAMURA, M
    TERASHITA, ZI
    OKUDA, H
    IMURA, Y
    SHINO, A
    NAKAO, M
    NISHIKAWA, K
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1993, 266 (03): : 1664 - 1669
  • [24] EFFECT OF AN ANGIOTENSIN-II RECEPTOR ANTAGONIST, CV-11974, AND ITS PRODRUG, TCV-116, ON PRODUCTION OF ALDOSTERONE
    WADA, T
    INADA, Y
    SANADA, T
    OJIMA, M
    SHIBOUTA, Y
    NODA, M
    NISHIKAWA, K
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 253 (1-2) : 27 - 34
  • [25] TCV-116, A NEWLY DEVELOPED ANGIOTENSIN-II RECEPTOR ANTAGONIST, INDUCES REGRESSION OF CARDIAC-HYPERTROPHY THROUGH SUPPRESSION OF THE TISSUE RENIN-ANGIOTENSIN SYSTEM IN SPONTANEOUSLY HYPERTENSIVE RATS
    MIZUNO, K
    NIIMURA, S
    KATOH, K
    FUKUCHI, S
    LIFE SCIENCES, 1994, 54 (25) : 1987 - 1994
  • [26] PERSISTENT INHIBITION OF THE PRESSOR AND ALDOSTERONE RESPONSES TO ANGIOTENSIN-II BY TCV-116 IN NORMOTENSIVE SUBJECTS
    OGIHARA, T
    NAGANO, M
    HIGAKI, J
    KOHARA, K
    MIKAMI, H
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 26 (03) : 490 - 494
  • [27] ANGIOTENSIN-II RECEPTOR ANTAGONIST, TCV-116 IMPROVES VIRUS-INDUCED MYOCARDIAL INJURY IN AN ANIMAL-MODEL
    MATSUMORI, A
    TANAKA, A
    WANG, WZ
    SASAYAMA, S
    CIRCULATION, 1994, 90 (04) : 452 - 452
  • [28] EFFECTS OF THE ANGIOTENSIN-II RECEPTOR ANTAGONIST, TCV-116, ON BLOOD-PRESSURE AND THE RENIN-ANGIOTENSIN SYSTEM IN HEALTHY-SUBJECTS
    OGIHARA, T
    NAGANO, M
    MIKAMI, H
    HIGAKI, J
    KOHARA, K
    AZUMA, J
    AOKI, T
    HAMANAKA, Y
    CLINICAL THERAPEUTICS, 1994, 16 (01) : 74 - 86
  • [29] TCV-116 stimulates eNOS and caveolin-1 expression and improves coronary microvascular remodeling in normotensive and angiotensin II-induced hypertensive rats
    Kobayashi, N
    Mori, Y
    Nakano, S
    Tsubokou, Y
    Kobayashi, T
    Shirataki, H
    Matsuoka, H
    ATHEROSCLEROSIS, 2001, 158 (02) : 359 - 368
  • [30] Oral administration of an AT1 receptor antagonist prevents the central effects of angiotensin II in spontaneously hypertensive rats
    Seltzer, A
    Bregonzio, C
    Armando, I
    Baiardi, G
    Saavedra, JM
    BRAIN RESEARCH, 2004, 1028 (01) : 9 - 18
12345